Chronic Pain Management

Introduction to Neuropathic Pain

Neuropathic pain can be managed with a multimodal approach, including pharmacological and non-pharmacological therapies, tailored to pain intensity, function, and associated symptoms, as recommended by the American Society of Anesthesiologists and the National Comprehensive Cancer Network 1, 2, 3

Amitriptyline is recommended as a first-line treatment for neuropathic pain, particularly for patients with peripheral neuropathic pain, starting at a dose of 10-25 mg at bedtime, with titration every 3-5 days as tolerated, and a target dose of 50-150 mg nightly, as recommended by the American Society of Anesthesiologists and the National Comprehensive Cancer Network 1, 2
Amitriptyline works through multiple mechanisms to relieve neuropathic pain, including inhibition of serotonin and norepinephrine reuptake, and has analgesic effects independent of its antidepressant activity 2

If amitriptyline is not tolerated or contraindicated, consider gabapentinoids (gabapentin, pregabalin), SNRIs (duloxetine, venlafaxine), or topical agents (lidocaine 5% patch, capsaicin) for localized peripheral neuropathic pain, as recommended by the National Comprehensive Cancer Network and other guidelines 4, 5, 3
Serotonin-Noradrenaline Reuptake Inhibitors, such as duloxetine or venlafaxine, have shown efficacy for musculoskeletal pain, particularly when pain is accompanied by depression or anxiety, with strong evidence (Level Ib, Strength A) 6

If there is an inadequate response to optimized amitriptyline dose, consider adding gabapentin (100-300 mg nightly, titrate to 900-3600 mg/day) or pregabalin (50 mg TID, titrate to 100-600 mg/day), as recommended by the National Comprehensive Cancer Network 2
Combination of pregabalin with amitriptyline targets different pain mechanisms and may allow for lower doses of each medication, potentially reducing side effects 7

If there is still an inadequate response, consider SNRIs (duloxetine 30-60 mg daily or venlafaxine 50-225 mg daily) or topical agents for localized pain, as recommended by the National Comprehensive Cancer Network and other guidelines 2, 5, 3
Opioids have limited efficacy for chronic low back pain, providing only short-term relief (mean difference of about 1 point on a 0-10 pain scale), and should be used with caution, as recommended by the American Urological Association and other guidelines 8
NSAIDs, such as naproxen 500mg BID or celecoxib 100mg BID, provide effective pain relief for back pain and can be added to the treatment regimen, as recommended by the American Urological Association and other guidelines 8

Heated pool treatment with or without exercise is recommended for improving symptoms in patients with fibromyalgia, with a moderate level of evidence (Level IIa, Strength B) 3
Individually tailored exercise programs, including aerobic exercise and strength training, are suggested for improving symptoms in patients with fibromyalgia, with a moderate level of evidence (Level IIb, Strength C) 3
Relaxation techniques, rehabilitation, and physiotherapy are recommended as complementary therapies for improving symptoms in patients with fibromyalgia, with a moderate level of evidence (Level IIb, Strength C) 3
Acupuncture has demonstrated statistically significant improvement in musculoskeletal symptoms, particularly effective for aromatase inhibitor-associated symptoms, as recommended by the National Comprehensive Cancer Network and other guidelines 9, 10
Cognitive behavioral therapy (CBT) is an effective treatment (Level Ia, Grade A) that helps patients develop coping strategies for pain management and addresses negative thought patterns that may amplify pain perception, as recommended by the American Urological Association and other guidelines 11

Patients with cardiovascular risk factors should undergo an ECG before starting treatment, and the medication should be used with caution in patients over 65 years old due to its anticholinergic effects, as recommended by the American Urological Association and other guidelines 12, 13, 4
Patients should be monitored for side effects such as changes in blood pressure, cognitive effects, sedation, dizziness, weight gain, and nausea, and the treatment should be reevaluated periodically to adjust the dose as necessary, as recommended by the American Urological Association and other guidelines 12, 14, 15, 16
Fibromyalgia medications such as pregabalin, duloxetine, and milnacipran should be continued through the perioperative period to prevent withdrawal symptoms and maintain pain control, with specific precautions for each medication, as recommended by the National Comprehensive Cancer Network and other guidelines 17
Pregabalin dosing should be adjusted in patients with renal insufficiency, as it is primarily eliminated by renal excretion, according to the National Kidney Foundation, with a high level of evidence 17